Literature DB >> 17251289

Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro.

Daniel N Streblow1, Koen W R van Cleef, Craig N Kreklywich, Christine Meyer, Patricia Smith, Victor Defilippis, Finn Grey, Klaus Früh, Robert Searles, Cathrien Bruggeman, Cornelis Vink, Jay A Nelson, Susan L Orloff.   

Abstract

Rat cytomegalovirus (RCMV) is a beta-herpesvirus with a 230-kbp genome containing over 167 open reading frames (ORFs). RCMV gene expression is tightly regulated in cultured cells, occurring in three distinct kinetic classes (immediate early, early, and late). However, the extent of viral-gene expression in vivo and its relationship to the in vitro expression are unknown. In this study, we used RCMV-specific DNA microarrays to investigate the viral transcriptional profiles in cultured, RCMV-infected endothelial cells, fibroblasts, and aortic smooth muscle cells and to compare these profiles to those found in tissues from RCMV-infected rat heart transplant recipients. In cultured cells, RCMV expresses approximately 95% of the known viral ORFs with few differences between cell types. By contrast, in vivo viral-gene expression in tissues from rat heart allograft recipients is highly restricted. In the tissues studied, a total of 80 viral genes expressing levels twice above background (5,000 to 10,000 copies per mug total RNA) were detected. In each tissue type, there were a number of genes expressed exclusively in that tissue. Although viral mRNA and genomic DNA levels were lower in the spleen than in submandibular glands, the number of individual viral genes expressed was higher in the spleen (60 versus 41). This finding suggests that the number of viral genes expressed is specific to a given tissue and is not dependent upon the viral load or viral mRNA levels. Our results demonstrate that the profiles, as well as the amplitude, of viral-gene expression are tissue specific and are dramatically different from those in infected cultured cells, indicating that RCMV gene expression in vitro does not reflect viral-gene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251289      PMCID: PMC1866122          DOI: 10.1128/JVI.02425-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  A subset of viral transcripts packaged within human cytomegalovirus particles.

Authors:  W A Bresnahan; T Shenk
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  Rat cytomegalovirus replication in the salivary glands is exclusively confined to striated duct cells.

Authors:  J S Kloover; J L Hillebrands; G de Wit; G Grauls; J Rozing; C A Bruggeman; P Nieuwenhuis
Journal:  Virchows Arch       Date:  2000-10       Impact factor: 4.064

4.  Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.

Authors:  Susan L Orloff; Daniel N Streblow; Cecilia Soderberg-Naucler; Qiang Yin; Craig Kreklywich; Christopher L Corless; Patricia A Smith; Christopher B Loomis; Lisa K Mills; Judith W Cook; Catherine A Bruggeman; Jay A Nelson; Cynthia R Wagner
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

5.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

6.  Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein.

Authors:  Julie A Heider; Wade A Bresnahan; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.

Authors:  Marielle C Gold; Michael W Munks; Markus Wagner; Ulrich H Koszinowski; Ann B Hill; Steven P Fling
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

9.  The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo.

Authors:  A Krmpotic; M Messerle; I Crnkovic-Mertens; B Polic; S Jonjic; U H Koszinowski
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.

Authors:  D G Kavanagh; M C Gold; M Wagner; U H Koszinowski; A B Hill
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  18 in total

1.  Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.

Authors:  Craig N Kreklywich; Patricia P Smith; Carmen Baca Jones; Anda Cornea; Susan L Orloff; Daniel N Streblow
Journal:  Methods Mol Biol       Date:  2014

2.  Simian varicella virus gene expression during acute and latent infection of rhesus macaques.

Authors:  Christine Meyer; Amelia Kerns; Alex Barron; Craig Kreklywich; Daniel N Streblow; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2011-11-04       Impact factor: 2.643

3.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

Review 4.  Acceleration of allograft failure by cytomegalovirus.

Authors:  Daniel N Streblow; Susan L Orloff; Jay A Nelson
Journal:  Curr Opin Immunol       Date:  2007-08-22       Impact factor: 7.486

5.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

6.  Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.

Authors:  Christopher M Snyder; Kathy S Cho; Elizabeth L Bonnett; Serani van Dommelen; Geoffrey R Shellam; Ann B Hill
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

7.  Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

Authors:  Alex Petrucelli; Michael Rak; Lora Grainger; Felicia Goodrum
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection.

Authors:  Lila A Farrington; Tameka A Smith; Finn Grey; Ann B Hill; Christopher M Snyder
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells.

Authors:  Christopher M Snyder; Jane E Allan; Elizabeth L Bonnett; Carmen M Doom; Ann B Hill
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

10.  Cytomegalovirus CC chemokine promotes immune cell migration.

Authors:  Jennifer Vomaske; Michael Denton; Craig Kreklywich; Takeshi Andoh; Jessica M Osborn; Daniel Chen; Ilhem Messaoudi; Susan L Orloff; Daniel N Streblow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.